BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  ICON Reports Second Quarter 2018 Results

  Excluding the impact of ASC 606, record net business wins in the quarter of $600 million; a book to bill of 1.27.

  July 25, 2018

   · 

  11 min read
• Drug Development

  KEYTRUDA® (pembrolizumab) Monotherapy Met a Primary Endpoint in the Phase 3 KEYNOTE-048 Trial, Significantly Improving OS as First-Line Therapy in Head and Neck Squamous Cell Carcinoma Patients Whose Tumors Expressed PD-L1 (CPS ≥20)

  KEYTRUDA is the First Anti-PD-1 Therapy to Show an Overall Survival Benefit as First-Line Therapy for Recurrent or Metastatic HNSCC

  July 25, 2018

   · 

  29 min read
• Policy

  Nevro Announces Patent Litigation Update

  Summary Judgment Ruling Affirms Method Claims Covering 1.5kHz to 100kHz Frequency Range

  July 25, 2018

   · 

  3 min read
• Business

  Indivior Announces H1 2018 Results

  Indivior Announces H1 2018 Results

  July 25, 2018

   · 

  100 min read
• Drug Development

  Minomic Announces Completion of Accrual for Clinical Study of Miltuximab® in Prostate, Bladder and Pancreatic Cancers

  No Drug-Related Adverse Effects Found in Patients

  July 25, 2018

   · 

  2 min read
• Business

  Medivir AB - Interim Report January - June 2018

  Successful progression of clinical projects

  July 25, 2018

   · 

  6 min read
• Biotech Beach

  EBD Group: Mobile Responsive Technology Powers Biotech-Pharma Business Growth through an Enhanced partneringONE® Conference Software Experience

  EBD Group has released a significant update of its gold-standard partnering software, partneringONE®, based on a fully responsive mobile platform.

  July 25, 2018

   · 

  3 min read
• Business

  Thermo Fisher Scientific Reports Second Quarter 2018 Results

  Thermo Fisher Scientific Inc. reported its financial results for the second quarter ended June 30, 2018.

  July 25, 2018

   · 

  43 min read
• Business

  John Whyte, MD, to Join WebMD as Chief Medical Officer

  Led Stakeholder Engagement for the FDA’s Center for Drug Evaluation and Research

  July 25, 2018

   · 

  2 min read
• Business

  Egalet to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results on August 8, 2018

  Egalet Corporation announced that its second quarter 2018 financial results will be released on Wednesday, August 8, 2018.

  July 25, 2018

   · 

  5 min read